EUVIMEDEUVIMED entdecken
Leitlinie

Consensus Guidelines for Staging and Surveillance Imaging in Cutaneous Squamous Cell Carcinoma

Bina Kassamali, Jonathan D Schoenfeld, Rosh Sethi, Richard L Bakst, Christopher A Barker, Alok A Bhatt, Carol R Bradford, Paul M Bunch, David R Carr, John A Carucci, Sunandana Chandra, Michelle Chen und 34 weitere

JAMA Dermatology · 01.09.2026 · 162 (9) · 939

DOI: 10.1001/jamadermatol.2026.2163 ↗

Kurz gefasst

Leitlinie in der Zeitschrift JAMA Dermatology, erschienen am 01.09.2026. Verfasst von Bina Kassamali und 45 weiteren Autor:innen. Beteiligte Einrichtung: Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Hauptthemen laut MEDLINE: Cutaneous Squamous Cell Carcinoma, Skin Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance There is no consensus on staging and surveillance imaging for cutaneous squamous cell carcinoma (CSCC). Although imaging has been shown to affect management, broad recommendations from the National Comprehensive Cancer Network have led to variability in clinical practice.

Objective

To develop multidisciplinary consensus recommendations on the use of staging and surveillance imaging of localized CSCC. Evidence Review A multidisciplinary expert panel across academic and clinical practice settings convened a Delphi consensus, with 3 iterative survey rounds from January to June 2025. Data were analyzed from February 2025 to January 2026. Eligibility defined by at least 1 to 2 CSCC publications during the previous 5 years, involvement in a relevant clinical trial, experience treating at least 3 patients monthly with CSCC, and/or 5 years or longer of clinical practice. Fifty-four experts were invited and 45 (83%) completed all 3 rounds and were included in the final analysis. Structured Delphi surveys evaluated clinical scenarios, imaging modalities, and surveillance strategies for CSCC. Consensus and near-consensus recommendations were generated, defined as 80% or greater and 70% to 79% agreement, respectively.

Findings

The 45 participants (21 female individuals [47%] and 24 male individuals [53%]; 14 Asian individuals [31%], 1 multiracial individual [2%], and 30 White individuals [67%]) consisted of dermatology (15 [33%]), medical oncology (7 [16%]), radiation oncology (9 [20%]), radiology (9 [20%]), surgery (3 [7%]), and otolaryngology specialists (2 [4%]). The Delphi panel recommended staging and surveillance for CSCCs with at least a 15% risk of metastasis. Consensus or near consensus was reached to recommend staging and surveillance imaging for tumors with a concern for metastasis, bone invasion, invasion beyond subcutaneous fat, large-caliber nerve invasion, or a diameter of 4 cm or larger or the combination of tumors with poorly differentiated histology and any of the following: diameter of 2 cm or larger, lymphovascular invasion and subcutaneous fat invasion, or lymphovascular invasion and small-caliber perineural invasion. Computed tomography imaging was the preferred modality for nodal staging (38 [84%]) and surveillance (35 [78%]). For surveillance duration, consensus was reached to provide imaging for at least 2 years, and near consensus was reached for at least 3 years. Conclusions and Relevance This study provides an expert consensus–based framework to standardize imaging in localized CSCC that may inform future guidelines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cutaneous Squamous Cell CarcinomaSkin NeoplasmsCarcinoma, Squamous CellHumansNeoplasm StagingDelphi TechniqueMaleFemale

Autor:innen und Institutionen

  • Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Mount Sinai School of Medicine, New York, New York.
  • Memorial Sloan Kettering Cancer Center, New York, New York.
  • Mayo Clinic, Jacksonville, Florida.
  • The Ohio State University College of Medicine, Columbus.

Zitieren

APA

Kassamali, B., Schoenfeld, J. D., Sethi, R., Bakst, R. L., Barker, C. A., Bhatt, A. A., Bradford, C. R., Bunch, P. M., Carr, D. R., Carucci, J. A., Chandra, S., Chen, M., Connolly, K. L., Demer, A. M., Doonan, B., Emerick, K., Friedman, B. J., Gali, L. L., Galloway, T. J., …, & Ruiz, E. S. (2026). Consensus Guidelines for Staging and Surveillance Imaging in Cutaneous Squamous Cell Carcinoma. JAMA Dermatology, 162(9), 939. https://doi.org/10.1001/jamadermatol.2026.2163

Vancouver

Kassamali B, Schoenfeld JD, Sethi R, Bakst RL, Barker CA, Bhatt AA, et al. Consensus Guidelines for Staging and Surveillance Imaging in Cutaneous Squamous Cell Carcinoma. JAMA Dermatology. 2026;162(9):939. doi:10.1001/jamadermatol.2026.2163

BibTeX
@article{Kassamali2026,
  author = {Kassamali, Bina and Schoenfeld, Jonathan D and Sethi, Rosh and Bakst, Richard L and Barker, Christopher A and Bhatt, Alok A and Bradford, Carol R and Bunch, Paul M and Carr, David R and Carucci, John A and Chandra, Sunandana and Chen, Michelle and Connolly, Karen L and Demer, Addison M and Doonan, Bently and Emerick, Kevin and Friedman, Ben J and Gali, Linna L and Galloway, Thomas J and Geiger, Jessica L and Guenette, Jeffrey P and Kelly, Hillary R and Khushalani, Nikhil I and Kohen, Laurie and Koyfman, Shlomo and Kumar, Shweta Sharat and Learned, Kim O and Leitenberger, Justin J and Lilley, Elizabeth J and Lukens, John Nicholas and Medina, Theresa and Mitra, Devarati and Ozog, David and Pashtan, Itai and Patel, Vishal Anil and Pham, Nancy and Powers, Molly C and Srivastava, Divya and Swiecicki, Paul L and Taylor, Charlotte S and Witek, Matthew E and Wysong, Ashley and Zander, David and Silk, Ann W and Jambusaria-Pahlajani, Anokhi and Ruiz, Emily S},
  title = {Consensus Guidelines for Staging and Surveillance Imaging in Cutaneous Squamous Cell Carcinoma},
  journal = {JAMA Dermatology},
  year = {2026},
  volume = {162},
  number = {9},
  pages = {939},
  doi = {10.1001/jamadermatol.2026.2163}
}
Kostenlos starten →